NM_032601.4:c.427C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_032601.4(MCEE):​c.427C>T​(p.Arg143Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00545 in 1,613,082 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R143H) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0053 ( 10 hom., cov: 31)
Exomes 𝑓: 0.0055 ( 45 hom. )

Consequence

MCEE
NM_032601.4 missense

Scores

9
5
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5O:1

Conservation

PhyloP100: 4.93

Publications

21 publications found
Variant links:
Genes affected
MCEE (HGNC:16732): (methylmalonyl-CoA epimerase) The product of this gene catalyzes the interconversion of D- and L-methylmalonyl-CoA during the degradation of branched chain amino acids. odd chain-length fatty acids, and other metabolites. Mutations in this gene result in methylmalonyl-CoA epimerase deficiency, which is presented as mild to moderate methylmalonic aciduria. [provided by RefSeq, Jul 2008]
MCEE Gene-Disease associations (from GenCC):
  • methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010361373).
BP6
Variant 2-71110074-G-A is Benign according to our data. Variant chr2-71110074-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 203810.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00533 (810/152052) while in subpopulation NFE AF = 0.0064 (435/67962). AF 95% confidence interval is 0.0059. There are 10 homozygotes in GnomAd4. There are 483 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCEENM_032601.4 linkc.427C>T p.Arg143Cys missense_variant Exon 3 of 3 ENST00000244217.6 NP_115990.3 Q96PE7
MCEEXM_005264613.3 linkc.265C>T p.Arg89Cys missense_variant Exon 3 of 3 XP_005264670.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCEEENST00000244217.6 linkc.427C>T p.Arg143Cys missense_variant Exon 3 of 3 1 NM_032601.4 ENSP00000244217.5 Q96PE7
MCEEENST00000413592.5 linkc.133C>T p.Arg45Cys missense_variant Exon 2 of 2 2 ENSP00000391140.1 H7BZS7
MCEEENST00000462609.2 linkn.373C>T non_coding_transcript_exon_variant Exon 5 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.00533
AC:
810
AN:
151934
Hom.:
10
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000991
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0290
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00640
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00549
AC:
1378
AN:
251090
AF XY:
0.00547
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.000840
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0262
Gnomad NFE exome
AF:
0.00633
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00546
AC:
7980
AN:
1461030
Hom.:
45
Cov.:
30
AF XY:
0.00540
AC XY:
3923
AN XY:
726844
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33456
American (AMR)
AF:
0.000872
AC:
39
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26120
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39666
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86226
European-Finnish (FIN)
AF:
0.0230
AC:
1228
AN:
53362
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5764
European-Non Finnish (NFE)
AF:
0.00577
AC:
6417
AN:
1111378
Other (OTH)
AF:
0.00340
AC:
205
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
358
717
1075
1434
1792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00533
AC:
810
AN:
152052
Hom.:
10
Cov.:
31
AF XY:
0.00650
AC XY:
483
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.000988
AC:
41
AN:
41500
American (AMR)
AF:
0.00105
AC:
16
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.0290
AC:
305
AN:
10534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00640
AC:
435
AN:
67962
Other (OTH)
AF:
0.00237
AC:
5
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00568
Hom.:
16
Bravo
AF:
0.00308
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00733
AC:
63
ExAC
AF:
0.00525
AC:
637
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00502
EpiControl
AF:
0.00462

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency Benign:3Other:1
Jun 19, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jul 31, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not provided Uncertain:1Benign:1
Jan 13, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MCEE: BS1, BS2 -

not specified Benign:1
Jul 01, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MCEE c.427C>T (p.Arg143Cys) results in a non-conservative amino acid change located in the vicinal oxygen chelate (VOC) domain (IPR037523) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0058 in 282430 control chromosomes (gnomAD), predominantly at a frequency of 0.026 within the Finnish subpopulation in the gnomAD database, including 15 homozygotes. The observed variant frequency within Finnish control individuals in the gnomAD database is approximately 52 fold of the estimated maximal expected allele frequency for a pathogenic variant in MCEE causing Methylmalonic Acidemia phenotype (0.0005), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Finnish origin. Six assessments for this variant have been submitted to ClinVar after 2014 with conflicting assessments (benign n=3, likely benign n=1, VUS n=1, pathogenic n=1). Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Uncertain
0.057
T
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.51
D;T
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.98
D;D
MetaRNN
Benign
0.010
T;T
MetaSVM
Uncertain
0.75
D
MutationAssessor
Pathogenic
4.3
.;H
PhyloP100
4.9
PrimateAI
Benign
0.47
T
PROVEAN
Pathogenic
-7.6
D;D
REVEL
Uncertain
0.62
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
.;D
Vest4
0.86
MVP
0.90
MPC
0.41
ClinPred
0.17
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.82
gMVP
0.92
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138436961; hg19: chr2-71337204; COSMIC: COSV54905209; API